Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

NO_LONGER_AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

December 31, 2006

Conditions
Chronic Myelogenous Leukemia
Interventions
DRUG

nilotinib

Trial Locations (18)

Unknown

Novartis Investigative Site, Calgary

Novartis Investigative Site, Edmonton

Novartis Investigative Site, Burnaby

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Moncton

Novartis Investigative Site, St. John's

Novartis Investigative Site, Halifax

Novartis Investigative Site, Brampton

Novartis Investigative Site, Hamilton

Novartis Investigative Site, London

Novartis Investigative Site, Oshawa

Novartis Investigative Site, Ottawa

Novartis Investigative Site, Windsor

Novartis Investigative Site, Montreal

Novartis Investigative Site, Québec

Novartis Investigative Site, Sherbrooke

Novartis Investigative Site, Saskatoon

q

Novartis Investigative Site, Toronto

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY